On this week’s show: Tracing the roots of Long Covid, and an argument against using the same DNA markers for suspects in law enforcement and in research labs for cell lines Two years into the pandemic, we’re still uncertain about the impact of Long Covid on the world—and up to 20% of COVID-19 patients might be at risk. First on the podcast this week, Staff Writer Jennifer Couzin-Frankel joins host Sarah Crespi to share a snapshot of the current state of Long Covid research, particularly what researchers think are likely causes. Also this week, Debra Mathews, assistant director for science programs in the Berman Institute of Bioethics and associate professor of genetic medicine at Johns Hopkins University, talks with Sarah about why everyone using the same DNA kits—from FBI to Interpol to research labs—is a bad idea. Finally, in a sponsored segment from the Science/AAAS Custom Publishing Office, Sean Sanders, director and senior editor for custom publishing, interviews Bobby Soni, chief business officer at the BioInnovation Institute (BII), about what steps scientists can take to successfully commercialize their ideas. This segment is sponsored by BII. This week’s episode was produced with help from Podigy. [Image: A. Mastin/Science; Music: Jeffrey Cook] [alt: illustration of potential causes for Long Covid ] Authors: Sarah Crespi; Jennifer Couzin-Frankel Episode page: https://www.science.org/doi/10.1126/science.add4887 About the Science Podcast: https://www.science.org/content/page/about-science-podcast Learn more about your ad choices. Visit megaphone.fm/adchoices

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related